FGF21 promotes ischaemic angiogenesis and endothelial progenitor cells function under diabetic conditions in an AMPK/NAD+‐dependent manner

Journal of Cellular and Molecular Medicine

Qiaoxia Dai¹  Shiyue Sun¹  Yi Tan¹  Guigui Zhang¹  Chunjie Gu¹  Xiaohong Pan¹  Xiaoqing Yan¹  Junhong He¹  Xia Fan¹  Hui Chen¹  Xue Meng¹  Xiangjuan Chen²  Haiqi Hu³  Xiao Ling⁴  Sun Da⁵  Chi Zhang⁶  Lechu Yu⁶  Xiaozhen Dai⁷  Kai Wang⁸  Yue Su⁹ 

[1] Chinese‐American Research Institute for Diabetic Complications, Department of Pharmacy, Wenzhou Medical University, Wenzhou, China;Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China;Department of Pharmacy, Jinhua Municipal Central Hospital, Jinhua, China;Department of Pharmacy, The People's Hospital of YuHuan, Taizhou, China;Institute of Life Sciences, Wenzhou University, Wenzhou, China;Ruian Center of Chinese‐American Research Institute for Diabetic Complications, the Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China;School of Biomedicine, Chengdu Medical College, Chengdu, China;The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China;The Second School of Medicine, Wenzhou Medical University, Wenzhou, China;

关键词: AMPK;    diabetes;    endothelial progenitor cells;    fibroblast growth factor 21;    NAD;   

DOI  :  10.1111/jcmm.16369

来源: Wiley

【 授权许可】

CC BY